Concepedia

Ryan Geschwindt

RG

9

Publications

336

Citations

9

H-Index

2001

Active since

Affiliations

Incyte (United States)(Current)

The University of Texas MD Anderson Cancer Center

University of Pennsylvania

Sarah Cannon

Institut Gustave Roussy

Ryan Geschwindt is an author at Incyte (United States) specializing in medicine, cancer therapeutics, and immunology.

Top concepts

Publications per year

2001–2023

9

Publications

9

MESOMARK™: A Potential Test for Malignant Pleural Mesothelioma

Heather L Beyer, Ryan Geschwindt, Curtis L. Glover et al. · Clinical Chemistry · 2007 · 141 citations · Full text

A randomized, double-blind, phase 2 study of ruxolitinib or placebo in combination with capecitabine in patients with advanced HER2-negative breast cancer and elevated C-reactive protein, a marker of systemic inflammation

Joyce O’Shaughnessy, Angela DeMichele, X. Cynthia et al. · Breast Cancer Research and Treatment · 2018 · 42 citations

, , +9

Detection of Newly Diagnosed Bladder Cancer, Bladder Cancer Recurrence and Bladder Cancer in Patients with Hematuria Using Quantitative RT-PCR of Urinary Survivin

Daniel M. Kenney, Ryan Geschwindt, Marcia R. Kary et al. · Tumor Biology · 2007 · 35 citations

A phase 1 study of oral ridaforolimus in pediatric patients with advanced solid tumors

Andrew D.J. Pearson, Sara M. Federico, Isabelle Aerts et al. · Oncotarget · 2016 · 28 citations · Full text

Phase I/II sequencing study of azacitidine, epacadostat, and pembrolizumab in advanced solid tumors

Jason J. Luke, Marwan Fakih, Charles Schneider et al. · British Journal of Cancer · 2023 · 27 citations · Full text

Rows per page

1–5 of 9